Neuronetics, Inc.

Date Founded
2001

Innovation
Using Transcranial Magnetic Stimulation (TMS), Neuronetics develops safe therapies for disorders of the central nervous system, including major depression, schizophrenia, OCD, mania and epilepsy.

Funding
The company has completed A, B, C, and D rounds of funding, raising a total of $99.4 million.

Contact
31 General Warren Blvd.
Malvern, PA 19355-1245
1.877.600.7555 phone
610.640.4206 fax

www.neuronetics.com